Results 61 to 70 of about 171,111 (167)

Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab

open access: yesNature Communications
The combination of toripalimab (an anti-PD-1 antibody) with definitive chemoradiotherapy (CRT) demonstrated encouraging efficacy against locally advanced esophageal squamous cell carcinoma (ESCC) in the EC-CRT-001 phase II trial (NCT04005170).
Baoqing Chen   +12 more
doaj   +1 more source

Higher 3-year recurrence-free survival rate in patients with complete pathological remission following neoadjuvant chemotherapy plus immunotherapy for esophageal cancer: a two-center, propensity score matching study

open access: yesFrontiers in Oncology
BackgroundNeoadjuvant therapy is preferentially recommended for resectable locally advanced esophageal malignancies, with patients who achieve pathological complete response (PCR) anticipated to have longer survival rates.
Hai Zhang   +12 more
doaj   +1 more source

Esophageal cancer

open access: yesAnnals of Cardiothoracic Surgery, 2017
Christopher, Harris   +2 more
openaire   +3 more sources

Machine learning technique-based four-autoantibody test for early detection of esophageal squamous cell carcinoma: a multicenter, retrospective study with a nested case–control study

open access: yesBMC Medicine
Background Autoantibodies represent promising diagnostic blood-based biomarkers that may be generated prior to the first clinically detectable signs of cancers.
Yi-Wei Xu   +10 more
doaj   +1 more source

Urban-rural disparities in survival of Chinese esophageal squamous cell carcinoma: a cohort study of 133,064 cases

open access: yesBMC Gastroenterology
Objective To compare urban-rural disparities in overall survival of patients with esophageal squamous cell carcinoma (ESCC) in China and identify independent prognostic factors.
Ran Wang   +21 more
doaj   +1 more source

NIR-responsive Cu2 − xSe@Fc nanoparticles for photothermal- ferroptosis combination therapy in esophageal cancer

open access: yesJournal of Nanobiotechnology
Esophageal cancer (EC) represents a highly recurrent and aggressive malignancy within the digestive system. However, conventional therapeutic strategies exhibit notable limitations in their clinical applications. Photothermal therapy (PTT), combined with
Linlin Shi   +11 more
doaj   +1 more source

Age of onset by temporal and spatial changes and prognostic value for esophageal cancer

open access: yesChinese Medical Journal
. Background:. Age plays a crucial role in the incidence and prognosis of esophageal cancer. In China, the age distribution of patients with esophageal cancer remains unclear, and comprehensive large-scale studies on its prognostic impact are lacking ...
Kan Zhong   +22 more
doaj   +1 more source

Prognostic value of immuno-inflammatory biomarkers in esophageal squamous cell carcinoma patients receiving immunotherapy combined with chemoradiotherapy and its association with immuno-genomic landscape

open access: yesBMC Cancer
Background The clinical significance of immuno-inflammatory indicators and the underlying biological basis in patients with esophageal squamous cell carcinoma (ESCC) who receive chemoradiotherapy (CRT) combined with immunotherapy remains unclear.
Xingyuan Cheng   +6 more
doaj   +1 more source

Global landscape of protein-coding and long non-coding RNA alternative splicing and regulation in the human esophageal squamous cell carcinoma

open access: yesCancer Cell International
Background Aberrant alternative splicing (AS) generates multiple isoforms from a single gene, leading to functional diversity and potentially contributing to tumorigenesis.
Yunfei Wang   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy